The two variants directly linked to liver cancer, ABCB4I490T and ABCB4S978P, expressed at reduced levels, 6 and 22%, respectively, relative to the expression of the WT transporter in the presence of ATP8B1/CDC50. Here, ATP8B1 is linked to liver cancer.